Skip to main content
Download PDF
Download ePub
  • Research article
  • Open access
  • Published:

Predictive value of ACEF score for clinical prognosis of patients with heavily calcified coronary lesions after percutaneous coronary intervention with rotational atherectomy

Journal of Cardiothoracic Surgery volume 17, Article number: 85 (2022) Cite this article

Abstract

Background

To inquiry the predictive value of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in patients diagnosed with heavily calcified coronary lesions at 1 year after percutaneous coronary intervention (PCI) with rotational atherectomy (RA).

Methods

275 patients with heavily calcified coronary lesions undergoing PCI with RA in the Department of Cardiology of Anhui Provincial Hospital from January 2017 to December 2019 were consecutively recruited. The primary endpoint event was cardiac death at postoperative 1 year. The ROC curve was used to assess ACEF scoring system and predict cardiac mortality.

Results

In term of ACEF score upon admission, 275 patients were divided into low-to-intermediate risk group (n = 130) with ACEF score < 1.23 and high-risk group (n = 145) with ACEF score ≥ 1.23. The age, gender proportion and left ventricular ejection fraction (LVEF) have a significant difference between the low-to-intermediate risk group and the high-risk group (all P < 0.05). The area under ROC curve for ACEF scoring system to predict cardiac mortality at 1 year after PCI with RA was 0.756 and 0.715, respectively.

Conclusions

ACEF value upon admission can predict the cardiac mortality at 1 year following PCI with RA in heavily calcified coronary lesions patients.

Peer Review reports

Background

Percutaneous coronary intervention (PCI) is one of the most important and effective treatment methods for coronary heart disease. Furthermore, with the advancement of PCI equipment and technology, more complicated coronary artery diseases have been successfully treated. However, there are still some special coronary artery diseases that cannot be completely overcome including heavily calcified coronary lesions. Heavily calcified coronary lesions can limit the effective pre-dilation of the balloon, increase the risk of complications such as coronary artery tearing, vascular dissection, difficulty in passing stents, perforation, poor stent attachment and no reflow, reduce the success rate of surgery, cause postoperative restenosis and thrombosis in the stent, and affect the long-term curative effect. Therefore, PCI treatment of heavily calcified coronary lesions is full of challenges [1]. Gratifyingly, lesion processing by an atherectomy strategy prior to PCI is an effective means for heavily calcified coronary lesions [2].

Recent studies have shown that rotational atherectomy (RA) with the Rotablator (Boston Scientific, Natick, MA, USA) contributes to treat heavily calcified coronary lesions. RA operate in a drill-like way, generating a maximum burr to vessel ratio of 0.7 [3]. RA can help stent release and adherence to the wall, improve the success rate of interventional therapy for severely calcified lesions, reduce the incidence of in-stent restenosis and in-stent thrombosis, and improve clinical prognosis. Therefore, according to the 2011 PCI guidelines, RA is recommended to treat the heavily calcified lesions or fibrotic that is difficult to penetrate or fully expand before stent placement (Class IIA recommendation) [4]. However, it is still very necessary and important to evaluate the risks and benefits (known as the risk stratification analysis) of RA on the patients with heavily calcified coronary lesions [5].

The ACEF score is a clinical risk score comprising age, creatinine, and left ventricular ejection fraction (LVEF) [6]. Although the ACEF score is originally proposed and validated in patients before undergoing coronary artery bypass grafting [7], it has been demonstrated to be applicable for PCI patients through multiple clinical trials [8, 9]. Our recent study has also shown that the ACEF value upon admission can predict the cardiac death rate at 1 month and 1 year after emergency PCI in STEMI patients aged ≥ 75 years old [10]. Furthermore, Pyxaras et al. [11] has exhibited that the ACEF score can predict major adverse cardiovascular events (MACE) in patients diagnosed with heavily calcified coronary stenosis at 1 year after RA with stent implantation. However, whether ACEF score can be utilized to predict the cardiac mortality in Chinese patients diagnosed with heavily calcified coronary lesions at 1 year after PCI with RA still need further reports.

In the present study, 275 patients with heavily calcified coronary lesions undergoing PCI with RA in the Department of Cardiology of Anhui Provincial Hospital from January 2017 to December 2019 were consecutively recruited to elucidate the predictive value of ACEF score for the cardiac death at 1 year after PCI with RA.

Methods

Study population

Patients with heavily calcified coronary lesions undergoing PCI with RA in the Department of Cardiology of Anhui Provincial Hospital from January 2017 to December 2019 were consecutively recruited in this clinical trial. Any of the following conditions were defined as heavily calcified coronary lesions: (1) Coronary angiography showed a clear and high-density image walking along the blood vessel wall, and it could also be appeared after the contrast agent is filled and the heart is not beating [12]. (2) Intravascular ultrasound showed that the hyperechoic light clusters distributed along the blood vessel wall are accompanied by sound shadows, and the lesions was with a range of ≥ 181° [13]. The study was performed in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Medical Ethics Committee of Anhui Provincial Hospital [Ethical approval number: 2019 KY Lun Shen No. 165] and informed consent was taken from all the patients.

Examinations and parameters

The examinations and parameters used in the present study were in accordance with our recent study [10].

Procedural Protocol

Rotablator III rotational atherectomy device (model H802220200381) was used for coronary RA. Rotatheter guide wire, head and propeller were adopted Rota WireTM (0.09 in × 330 cm, 1 in = 2.54 cm) (Boston Scientific, USA), Rota Link M (diameters are 1.25 mm, 1.50 mm and 1.75 mm) (Boston Scientific, USA), and Rota Link M (Boston Scientific, USA), respectively. Rotary atherectomy washing solution [saline 500 ml, nitroglycerin 2 mg, heparin 5000 U; pressure 150–200 mmHg (1 mmHg = 0.133 kPa)] was used for pressure perfusion. Before the start of RA, patients were received heparin with a dosage of 60–100 U/kg, and then added 1000–2000 U/h to maintain activated coagulation time (ACT) > 300 s. Before and after coronary RA, nitroglycerin with a dosage of 50–200 μg was given in the coronary arteries as appropriate. The RA was executed at a rotation speed of 14–18 × 104 r/min, with a rotation time of each rotary grinding of 15–30 s, and with a time interval of 30–120 s. The procedural protocol of coronary angiography used in the present study were in accordance with our recent study [10].

ACEF scoring analysis

The ACEF score was analyzed based on the following formula: ACEF = age/left ventricular ejection fraction (%) + 1 (if creatinine was > 2.0 mg/dL). All patients were divided into tertiles according to the ACEF score [14].

Primary and secondary endpoint events

The primary endpoint event of the study was cardiac mortality within postoperative 1 year. Secondary endpoint events contained death (cardiogenic and non-cardiogenic), bleeding (BARC classification), stent thrombosis, recurrent myocardial infarction, complete revascularization, stent restenosis (ISR), and cerebral infarction within 1 year after PCI with RA. All patients were followed up by outpatient, medical record or telephone call. The follow-up time was 1 year or until the end-point event occurred.

Statistical analysis

Data in this present study were analyzed using SPSS 20.0 statistical software. All the measurement data in the present study were expressed as mean ± standard deviation (SD) and analyzed with the t-test, while all the count data were expressed as percentage (%) and analyzed by the chi-square test using SPSS 20.0 statistical software (SPSS Inc., Chicago, IL, U.S.). The ROC curve was used to evaluate the ACEF scoring system to predict the postoperative 1-year mortality rate. Cox regression model was executed using univariate analysis. P < 0.05 was indicated as statistically significant.

Results

Patient grouping

275 patients with heavily calcified coronary lesions undergoing PCI with RA from January 2017 to December 2019 in the Department of Cardiology of Anhui Provincial Hospital were consecutively recruited in this clinical trial. There were 163 male and 112 female patients respectively. Based on the ACEF score upon admission, all patients were divided into the low-to-intermediate risk group (n = 130) and high-risk group (n = 145). In the low-to-intermediate risk group, there were 67 males and 63 females with a mean age of 68.40 ± 8.39 years old. In the high-risk group, 96 patients were male and 49 females, aged 73.27 ± 8.76 years on average.

Baseline data

As shown in Table 1, the difference of hypertension, stroke, prior myocardial infarction (MI), diabetes mellitus, renal insufficiency and smoking between the low-to-intermediate risk and high-risk groups was not statistical significance (all P > 0.05). There was no significant difference in the cases of previous PCI, coronary artery bypass graft surgery (CABG) and peripheral artery disease (PAD) between the two groups (all P > 0.05). However, a mean age of 68.40 ± 8.39 years old in the low-to-intermediate risk group was prominently lower than that with 73.27 ± 8.76 years in the high-risk group (P < 0.001). The gender proportion between the low-to-intermediate risk and high-risk groups was also significant difference, as indicated with 67 male patients in the low-to-intermediate risk group and 96 male patients in the high-risk group (P = 0.013). Moreover, the incidence of chronic obstructive pulmonary disease (COPD) was higher in the high-risk group than in the low-to intermediate risk group (P = 0.002). Additionally, the LVEF in the low-to-intermediate risk group was surveyed as 66.36 ± 7.09, notably higher compared with 47.09 ± 11.32 in the high-risk group (P < 0.001).

Table 1 Comparison of baseline data between two groups
Full size table

PCI outcomes

As elucidated in Table 2, all the PCI parameters including IRA (P = 0.333), IABP (2.3% versus 5.5%, P = 0.175), arterial puncture route (P = 0.293) and mean stent number (2.50 ± 0.874 vs. 2.64 ± 1.07, P = 0.233) did not observably differ between the low-to-intermediate risk group and high-risk group.

Table 2 Comparison of PCI parameters between two groups
Full size table

Clinical outcomes

Table 3 presents the clinical outcomes within 30 days and 1 year after PCI. There was no significant difference in stroke, bleeding events (BARC 3 to 5), and incidence of MI within 30 days and 1 year after PCI between the low-to-intermediate risk and high-risk groups. Compared to the low-to-intermediate risk group, patients in the high-risk group had higher cardiac mortality within 30 days after PCI (P = 0.019), while no favorable outcome was found in cardiac mortality within 1 year after PCI between the two groups.

Table 3 Comparison of clinical outcomes between two groups
Full size table

ROC curve analysis

The area under the ROC curve of the ACEF scoring system in predicting cardiac death at 1 year after PCI was calculated as 0.756 (P = 0.003), as exhibited in Fig. 1. Additionally, the sensitivity and specificity of the ACEF scoring system in predicting cardiac death at 1 year after PCI was 75.0% and 72.6%, respectively.

Fig. 1
figure 1

ROC curve of the ACEF scoring system in predicting cardiac death at 1 year after PCI. ACEF, age, creatinine and ejection fraction; RA, rotational atherectomy; PCI, percutaneous coronary intervention

Full size image

Furthermore, the area under the ROC curve of the ACEF scoring system in predicting cardiac death at 1 year after LAD-PCI was calculated as 0.715 (P = 0.04), as illustrated in Fig. 2. Additionally, the sensitivity and specificity of the ACEF scoring system in predicting cardiac death at 1 year after LAD-PCI was 75.0% and 70.0%, respectively.

Fig. 2
figure 2

ROC curve of the ACEF scoring system in predicting cardiac death at 1 year after LAD-PCI. ACEF, age, creatinine and ejection fraction; LAD, left anterior descending oronary artery; PCI, percutaneous coronary intervention

Full size image

Discussion

With the increase of age, coronary atherosclerosis in patients with coronary heart disease is dynamically evolving. The plaques develop and begin to appear calcified plaques, and smooth muscle cells and foam cells begin to mineralize, which promotes the deposition of calcium salts in the plaques to cause calcification. Rotational atherectomy has been demonstrated for the preparation of undilatable lesion including heavily calcified coronary lesions to implant the stent, thereby improving procedural success of PCI. Therefore, an accurate risk assessment based on the overall rate of MACE is very imperative and significant due to clinical needs.

The variety of risk-assessment models have been used for risk stratification of the patients with PCI. For instance, EUROScore and modified EUROScore have been constructed for patients undergoing PCI [15, 16]. SYNTAX score has a predictive value for unprotected left-main coronary artery (uLMCA) patients with PCI [17]. However, the SYNTAX score is notably involved in worse three-year outcomes [17]. In addition, the Clinical SYNTAX score (CSS) also has been reported to show a predictive value in patients with heavily calcified coronary stenosis undergoing RA with stent implantation [11]. The ACEF score, containing three core parameters of age, creatinine and LVEF, is simple and handy risk- stratification model for PCI, which has been confirmed by our team in STEMI patients aged ≥ 75 years old [10], as well as other groups [8, 18, 19]. The age, gender proportion and LVEF between the low-to-intermediate risk and high-risk groups was significant difference, but the PCI parameters between the two groups had no statistical difference, which suggested the application of ACEF score between the two groups in the present study. Furthermore, the predictive value of ACEF score for clinical prognosis of patients diagnosed with heavily calcified coronary lesions after PCI with RA was assessed. The ROC curve analysis revealed that the ACEF score could effectively differentiate the short-term mortality rate of 275 incorporated patients diagnosed with heavily calcified coronary lesions and have predictive value, which was accordance with previous study reported that ACEF score can predict MACE in patients diagnosed with heavily calcified coronary stenosis at 1 year after RA with stent implantation [11].

However, there are still some limitations that need to further improve. For example, the duration time of the follow-up is 1 year, the sample size is relatively small, and all patients incorporated in the present study are from a single center. Therefore, results of extended duration of follow-up with bigger sample size from multiple centers can underpin the conclusion shown in the present study.

Conclusions

ACEF value upon admission can predict the cardiac death rate at 1 year after PCI with RA in heavily calcified coronary lesions patients.

Availability of data and materials

Not applicable.

Abbreviations

ACEF:

Age, creatinine, and ejection fraction

PCI:

Percutaneous coronary intervention

RA:

Rotational atherectomy

LVEF:

Left ventricular ejection fraction

MACE:

Major adverse cardiovascular events

ACT:

Activated coagulation time

ISR:

Revascularization, stent restenosis

SD:

Standard deviation

uLMCA:

Unprotected left-main coronary artery

CSS:

Clinical SYNTAX score

References

  1. Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Lombardi W, Wyman MR, Doing A, Moses JW, Kirtane A, Parikh M, Ali Z, Kandzari D, Lembo N, Garcia S, Danek BA, Karatasakis A, Resendes E, Kalsaria P, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. Impact of calcium on chronic total occlusion percutaneous coronary interventions. Am J Cardiol. 2017;120(1):40–6.

    Article  CAS  Google Scholar 

  2. Moussa I, Di Mario C, Moses J, Reimers B, Di Francesco L, Martini G, Tobis J, Colombo A. Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiogr Clin Follow-up Res Circ. 1997;96(1):128–36.

    CAS  Google Scholar 

  3. Abdel-Wahab M, Richardt G, Joachim Büttner H, Toelg R, Geist V, Meinertz T, Schofer J, King L, Neumann FJ, Khattab AA. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. JACC Cardiovasc Interv. 2013;6(1):10–9.

    Article  Google Scholar 

  4. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):e574–651.

    PubMed  Google Scholar 

  5. Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, Wang TY, Gibler WB, Ohman EM, Roe MT, Pollack CV Jr, Peterson ED, Alexander KP. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with early implementation of the ACC/AHA Guidelines) bleeding score. Circulation. 2009;119(14):1873–82.

    Article  Google Scholar 

  6. Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009;119(24):3053–61.

    Article  Google Scholar 

  7. Sullivan PG, Wallach JD, Ioannidis JP. Meta-analysis comparing established risk prediction models (EuroSCORE II, STS Score, and ACEF Score) for perioperative mortality during cardiac surgery. Am J Cardiol. 2016;118(10):1574–82.

    Article  Google Scholar 

  8. Di Serafino L, Borgia F, Maeremans J, Pyxaras SA, De Bruyne B, Wijns W, Heyndrickx G, Dens J, Di Mario C, Barbato E. The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion. Am J Cardiol. 2014;114(8):1158–64.

    Article  Google Scholar 

  9. Lee JH, Bae MH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Cho MC, Kim CJ, Chae SC, Korea Acute Myocardial Infarction Registry Investigators. Prognostic value of the age, creatinine, and ejection fraction score for 1-year mortality in 30-day survivors who underwent percutaneous coronary intervention after acute myocardial infarction. Am J Cardiol. 2015;115(9):1167–73.

    Article  Google Scholar 

  10. Chen H, Yu X, Kong X, Li L, Wu J, Ma L. Predictive value of ACEF score for clinical prognosis of elderly patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention. Ann Palliat Med. 2021;10(2):1380–7.

    Article  Google Scholar 

  11. Pyxaras SA, Mangiacapra F, Wijns W, Di Serafino L, De Vroey F, Toth G, Sinagra G, De Bruyne B, Heyndrickx GR, Barbato E. ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation. Catheter Cardiovasc Interv. 2014;83(7):1067–73.

    Article  Google Scholar 

  12. Chiang MH, Lee WL, Tsao CR, Chang WC, Su CS, Liu TJ, Liang KW, Ting CT. The use and clinical outcomes of rotablation in challenging cases in the drug-eluting stent era. J Chin Med Assoc. 2013;76(2):71–7.

    Article  Google Scholar 

  13. Tuzcu EM, Berkalp B, De Franco AC, Ellis SG, Goormastic M, Whitlow PL, Franco I, Raymond RE, Nissen SE. The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound. J Am Coll Cardiol. 1996;27(4):83283–8.

    Google Scholar 

  14. Alnasser SM, Huang W, Gore JM, Steg PG, Eagle KA, Anderson FA Jr, Fox KA, Gurfinkel E, Brieger D, Klein W, van de Werf F, Avezum Á, Montalescot G, Gulba DC, Budaj A, Lopez-Sendon J, Granger CB, Kennelly BM, Goldberg RJ, Fleming E, Goodman SG, GRACE Investigators. Late consequences of acute coronary syndromes: global registry of acute coronary events (GRACE) follow-up. Am J Med. 2015;128(7):766–75.

    Article  Google Scholar 

  15. Coluccia V, Burzotta F, Romagnoli E, Trani C, Giammarinaro M, Talarico GP, Jannelli GV, Niccoli G, Porto I, Leone AM, Tommasino A, Schiavoni G, Crea F. EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions. Int J Cardiol. 2013;167(4):1232–6.

    Article  Google Scholar 

  16. Tian R, Xu H, Lv S. The use of a modified EuroSCORE to evaluate mortality risk in percutaneous coronary intervention. Ann Thorac Cardiovasc Surg. 2014;20(1):32–7. https://doi.org/10.5761/atcs.oa.12.01985.

    Article  PubMed  Google Scholar 

  17. Shiyovich A, Perl L, Vaknin-Assa H, Greenberg G, Samara A, Kornowski R, Assali A. Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery according to the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score. Coron Artery Dis. 2020;31(4):336–41.

    Article  Google Scholar 

  18. Kalaycı A, Oduncu V, Geçmen Ç, Topcu S, Karabay CY, İzgi İA, Kırma C. A simple risk score in acute ST-elevation myocardial infarction: Modified ACEF(age, creatinine, and ejection fraction) score. Turk J Med Sci. 2016;46(6):1688–93.

    Article  Google Scholar 

  19. Dziewierz A, Siudak Z, Rakowski T, Zasada W, Krzanowska K, Dudek D. The ACEF (age, creatinine, ejection fraction) score predicts ischemic and bleeding outcomes of patients with acute coronary syndromes treated conservatively. Postepy Kardiol Interwencyjnej. 2017;13(2):160–4.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This research was funded by National Natural Science Foundation of China [Grant Nos.81870192 and 82170263].

Author information

Author notes

  1. Hongwu Chen and Xiaofan Yu are the first authors

Authors and Affiliations

  1. Department of Cardiology, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, No. 17 Lujiang Road, Luyang District, Hefei, 230001, Anhui Province, China

    Hongwu Chen, Xiaofan Yu, Guangquan Qiu & Likun Ma

Authors
  1. Hongwu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaofan Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guangquan Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Likun Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HWC is resposible for the study concepts and design, literature research, experimental studies, data analysis and analysis, statistical analysis, manuscript preparation; XFY and GQQ are resposible for the study concepts, literature research, data acquisition, manuscript editing; LKM is resposible for the guarantor of integrity of the entire study, study concepts and design, definition of intellectual content, clinical studies, data acquisition and acquisition, manuscript editing and review. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Likun Ma.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Medical Ethics Committee of Anhui Provincial Hospital [Ethical approval number: 2019 KY Lun Shen No. 165]. and informed consent was taken from all the patients.

Consent for publication

Not applicable.

Competing interests

There are no potential conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, H., Yu, X., Qiu, G. et al. Predictive value of ACEF score for clinical prognosis of patients with heavily calcified coronary lesions after percutaneous coronary intervention with rotational atherectomy. J Cardiothorac Surg 17, 85 (2022). https://doi.org/10.1186/s13019-022-01833-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13019-022-01833-7

Keywords

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us